Istituto di Chimica Biomolecolare-CNR, Sassari, Italy.
Oncol Rep. 2011 Apr;25(4):899-904. doi: 10.3892/or.2011.1169. Epub 2011 Jan 31.
A cohort of 206 consecutively-collected patients with colorectal carcinoma (CRC) were screened for germline mutations in the principal DNA mismatch repair (MMR) genes, MLH1 and MSH2, and in the Fanconi anemia (FA) genes involved in homologous recombination DNA repair. Mutation analysis was performed by denaturing high-performance liquid chromatography (DHPLC) and automated sequencing. Available paraffin-embedded tumor tissues were evaluated for gene expression by immunohistochemistry. Genes of the FA pathway were found to participate in CRC pathogenesis, being silenced during disease progression and metastasis formation. Conversely, MLH1 and MSH2 genes seem to be inactivated at earlier stages of the disease. Finally, very few (about 5%) cases presented a simultaneous inactivation of the MMR and FA genes. Overall, our findings indicated that: i) mismatch DNA repair remains the main mechanism to be altered at both germline and somatic levels among CRC patients; ii) functional impairments of mismatch DNA repair and FA-related repair may represent two different pathogenetic alterations which are concurring in colorectal cancer progression.
我们对 206 例连续收集的结直肠癌(CRC)患者进行了种系 DNA 错配修复(MMR)主要基因 MLH1 和 MSH2 以及同源重组 DNA 修复中涉及的范可尼贫血(FA)基因的突变筛选。通过变性高效液相色谱(DHPLC)和自动测序进行突变分析。通过免疫组织化学评估可用的石蜡包埋肿瘤组织的基因表达。FA 途径的基因参与 CRC 的发病机制,在疾病进展和转移形成过程中失活。相反,MLH1 和 MSH2 基因似乎在疾病的早期阶段失活。最后,只有极少数(约 5%)病例同时失活 MMR 和 FA 基因。总的来说,我们的研究结果表明:i)错配 DNA 修复仍然是 CRC 患者种系和体细胞水平上主要改变的机制;ii)错配 DNA 修复和 FA 相关修复的功能障碍可能代表两种不同的发病改变,它们在结直肠癌进展中同时发生。